What is the role of serum ferritin measurement in dengue fever, including optimal timing, interpretation of level thresholds, and implications for patient management?

Serum Ferritin as a Prognostic Biomarker in Dengue Fever

Serum ferritin should be measured at first contact in dengue patients as a prognostic biomarker to identify those at risk for severe disease, with levels ≥593 ng/mL indicating high risk for severe thrombocytopenia and levels ≥1,200 ng/mL predicting dengue hemorrhagic fever.

Role and Clinical Utility

Serum ferritin functions as an acute-phase reactant that correlates strongly with dengue severity. The evidence demonstrates that higher ferritin levels consistently predict progression to severe dengue, dengue hemorrhagic fever (DHF), and complications like severe thrombocytopenia 1, 2.

Key Threshold Values

The research establishes two clinically actionable cut-offs:

• 593 ng/mL threshold: A first-contact ferritin below this level has 93-100% sensitivity and 98-100% negative predictive value for ruling out severe thrombocytopenia (<20,000/µL). Patients below this threshold are unlikely to develop severe thrombocytopenia regardless of clinical presentation 2.

• 1,200 ng/mL threshold: This level predicts dengue hemorrhagic fever with sensitivities of 81.5% (Day 5), 84.4% (Day 6), and 89.9% (Day 7) of illness 3. The meta-analysis confirms severe dengue cases show markedly elevated ferritin compared to non-severe cases (SMD 4.05) 1.

Optimal Timing for Measurement

Measure ferritin at first patient contact (Day 1 of presentation) and repeat on Day 4 for optimal prognostic value:

• Day 1 (febrile phase): Ferritin is a "good" predictor with AUC 0.863, allowing early risk stratification 4
• Day 4 (defervescence): Ferritin becomes an "excellent" predictor with AUC 0.947, coinciding with the critical phase when plasma leakage and complications develop 4

Serial monitoring on Days 5-7 provides additional prognostic information, as ferritin levels peak during the critical phase in DHF patients (median 1,912-2,105 ng/mL) compared to dengue fever patients (median 615-1,075 ng/mL) 3.

Interpretation by Disease Severity

The ferritin gradient across disease categories is substantial 1:

• Dengue without warning signs (DwoWS): Baseline/lower levels
• Dengue with warning signs (DwWS): Intermediate elevation (SMD 2.01 higher than DwoWS)
• Severe dengue: Markedly elevated (SMD 2.66 higher than DwWS; SMD 6.65 higher than DwoWS)

Mean ferritin in severe dengue reaches 9,125 µg/L versus 4,271 µg/L in non-severe cases 5.

Clinical Management Implications

Risk Stratification Algorithm

1. First contact: Measure ferritin immediately

   • <593 ng/mL: Low risk for severe thrombocytopenia; consider outpatient management with close monitoring
   • 593-1,200 ng/mL: Intermediate risk; hospitalize for observation through critical phase (Days 3-7)
   • ≥1,200 ng/mL: High risk for DHF; hospitalize with intensive monitoring for plasma leakage, hemorrhage, and shock

2. Day 4 reassessment: Repeat ferritin

   • Rising or persistently elevated levels warrant escalation of monitoring intensity
   • Prepare for aggressive fluid resuscitation and blood product availability

Important Caveats

Ferritin is not specific to dengue—elevated levels occur in various inflammatory conditions, hemophagocytic lymphohistiocytosis (HLH), liver disease, and other infections 5, 6. The diagnosis must integrate:

• Serologic confirmation of dengue (IgM antibodies after Day 5, or RT-PCR/NS1 antigen in first 5-7 days) 7
• Clinical findings (warning signs: abdominal pain, persistent vomiting, mucosal bleeding, lethargy)
• Platelet count and hematocrit trends
• Imaging for plasma leakage (gallbladder wall edema, pleural effusions, ascites)

Testing method affects results: The meta-analysis identified ferritin assay methodology as a significant source of heterogeneity 1. Use consistent laboratory methods for serial measurements.

Prognostic Associations

Beyond thrombocytopenia and DHF, elevated ferritin correlates with:

• Hemorrhagic complications: Mean ALT, AST, and bilirubin are significantly higher in patients with hemorrhage 8
• Mortality risk: Non-survivors have significantly higher ferritin levels 4
• HLH development: Extremely elevated ferritin (>8,613 ng/mL) suggests possible HLH, though soluble IL-2R is more specific 6

Practical Implementation

Ferritin measurement should be standard in dengue evaluation because it is:

• Inexpensive and widely available
• Provides actionable risk stratification at first contact
• Guides decisions on hospitalization versus outpatient management
• Identifies patients requiring intensive monitoring during the critical phase

The negative predictive value of low ferritin (<593 ng/mL) is particularly valuable for safely identifying patients who can be managed as outpatients with daily monitoring, reducing unnecessary hospitalizations in endemic areas with high case volumes 2.